Hemcheck Sweden AB (publ) (HEMC.ST) Research

Hemcheck Sweden AB (publ) is a Swedish medical technology company. They specialize in developing and marketing Helge, a device capable of identifying hemolysis in blood samples at the point of care. The company's services are primarily aimed at emergency departments within the European Union and the United States. Hemcheck was founded in 2010 and is based in Karlstad, Sweden.

Market snapshot

Symbol
HEMC.ST
Price
$0.23
Day change
+26.11%
Market cap
$8.6M
P/E ratio
-0.24x
52-week range
0.0848-1.25
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Bonzun AB (publ) (BONZUN.ST)
  • Cline Scientific AB (publ) (CLINE-B.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Duearity AB (publ) (DEAR.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Learning 2 Sleep L2S AB (publ) (L2S.ST)
  • Pexa AB (PEXAB.ST)
  • Pharmiva AB (publ) (PHARM.ST)

Open Hemcheck Sweden AB (publ) (HEMC.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.